Exact Mass: 356.22255700000005

Exact Mass Matches: 356.22255700000005

Found 64 metabolites which its exact mass value is equals to given mass value 356.22255700000005, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

5,7-Megastigmadien-9-ol glucoside

2-(hydroxymethyl)-6-{[(3E)-4-(2,6,6-trimethylcyclohex-1-en-1-yl)but-3-en-2-yl]oxy}oxane-3,4,5-triol

C19H32O6 (356.2198772)

5,7-Megastigmadien-9-ol glucoside is found in fruits. 5,7-Megastigmadien-9-ol glucoside is a constituent of Passiflora edulis (passion fruit). Constituent of Passiflora edulis (passion fruit). 5,7-Megastigmadien-9-ol glucoside is found in fruits.

AB-Chminaca

N-(1-(Aminocarbonyl)-2-methylpropyl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide

C20H28N4O2 (356.2212148)

Rolofylline

1,3-dipropyl-8-{tricyclo[3.3.1.0³,⁷]nonan-3-yl}-2,3,6,7-tetrahydro-1H-purine-2,6-dione

C20H28N4O2 (356.2212148)

3-(Hydroperoxymethyl)-6-(1-hydroxy-1-methylundecyl)-4-methoxy-2H-pyran-2-one

C19H32O6 (356.2198772)

Ab-chminaca, (+/-)-

C20H28N4O2 (356.2212148)

N-(1-amino-3-methyl-1-oxobutan-2-yl)-2-(cyclohexylmethyl)-2h-indazole-3-carboxamide

C20H28N4O2 (356.2212148)

C19H32O6

C19H32O6 (356.2198772)

3-(hydroperoxymethyl)-6-(2-hydroxydodecan-2-yl)-4-methoxy-2H-pyran-2-one|peroxymonascuspyrone

C19H32O6 (356.2198772)

(6R,9R)-3-oxo-alpha-ionol-9-O-beta-D-glucopyranoside|4-(2,6,6-trimethyl-2-cyclohexen-1-yl)-3-buten-2-ol

C19H32O6 (356.2198772)

(-)-octalactin A|4(R),5(S),8(S)-4-hydroxy-8-{2-[3-((S)-2-hydroxy-3-methyl-butyl)-2(S),3(R)-2-methyl-oxiranyl]-1(S)-methyl-2-oxo-ethyl}-5-methyl-oxocan-2-one|Octalactin A

C19H32O6 (356.2198772)

15alpha-methoxy-O-methyldihydrobotrydial

C19H32O6 (356.2198772)

C26H28O

C26H28O (356.2140038)

(2-{4,5-Dimethoxy-2-[2-(4-methoxy-phenyl)-vinyl]-phenyl}-ethyl)-trimethyl-ammonium

"NCGC00160197-01!(2-{4,5-Dimethoxy-2-[2-(4-methoxy-phenyl)-vinyl]-phenyl}-ethyl)-trimethyl-ammonium"

[C22H30NO3]+ (356.22255700000005)

(2E,4E)-12-hydroxy-13-(hydroxymethyl)-14-methoxy-3,5,7-trimethyl-14-oxotetradeca-2,4-dienoic acid

NCGC00380990-01!(2E,4E)-12-hydroxy-13-(hydroxymethyl)-14-methoxy-3,5,7-trimethyl-14-oxotetradeca-2,4-dienoic acid

C19H32O6 (356.2198772)

(2E,4E)-12-hydroxy-13-(hydroxymethyl)-14-methoxy-3,5,7-trimethyl-14-oxotetradeca-2,4-dienoic acid [IIN-based on: CCMSLIB00000847299]

NCGC00380990-01!(2E,4E)-12-hydroxy-13-(hydroxymethyl)-14-methoxy-3,5,7-trimethyl-14-oxotetradeca-2,4-dienoic acid [IIN-based on: CCMSLIB00000847299]

C19H32O6 (356.2198772)

(2E,4E)-12-hydroxy-13-(hydroxymethyl)-14-methoxy-3,5,7-trimethyl-14-oxotetradeca-2,4-dienoic acid [IIN-based on: CCMSLIB00000847297]

NCGC00380990-01!(2E,4E)-12-hydroxy-13-(hydroxymethyl)-14-methoxy-3,5,7-trimethyl-14-oxotetradeca-2,4-dienoic acid [IIN-based on: CCMSLIB00000847297]

C19H32O6 (356.2198772)

(2E,4E)-12-hydroxy-13-(hydroxymethyl)-14-methoxy-3,5,7-trimethyl-14-oxotetradeca-2,4-dienoic acid [IIN-based: Match]

NCGC00380990-01!(2E,4E)-12-hydroxy-13-(hydroxymethyl)-14-methoxy-3,5,7-trimethyl-14-oxotetradeca-2,4-dienoic acid [IIN-based: Match]

C19H32O6 (356.2198772)

5,7-Megastigmadien-9-ol glucoside

2-(hydroxymethyl)-6-{[(3E)-4-(2,6,6-trimethylcyclohex-1-en-1-yl)but-3-en-2-yl]oxy}oxane-3,4,5-triol

C19H32O6 (356.2198772)

FA 19:3;O4

methyl 11-(3,5-epidioxy-2-ethyl-cyclopentyl)-9-hydroperoxy-10-undecenoate

C19H32O6 (356.2198772)

FAL 26:12

(2E,4E,6E,8E,10E,12E,14E,16E,18E,20E,22E,24E,26E)-hexacosa-2,4,6,8,10,12,14,16,18,20,22,24,26-dodecaenal

C26H28O (356.2140038)

ethyl prop-2-enoate,8-methyl-2-methylidenenonanoic acid,prop-2-enoic acid

C19H32O6 (356.2198772)

butyl 2-methylprop-2-enoate,butyl prop-2-enoate,2-methylprop-2-enoic acid

C19H32O6 (356.2198772)

ethenyl acetate,6-methylheptyl prop-2-enoate,2-methylprop-2-enoic acid

C19H32O6 (356.2198772)

ETHYLTRIBUTYLPHOSPHONIUM ETHYL SULFATE

C16H37O4PS (356.21500520000006)

Rolofylline

C20H28N4O2 (356.2212148)

D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D045283 - Natriuretic Agents > D004232 - Diuretics Rolofylline (KW-3902) is a potent, selective adenosine A1 receptor antagonist that is under development for the treatment of patients with acute congestive heart failure and renal impairment. Rolofylline is metabolized primarily to the pharmacologically active M1-trans and M1-cis metabolites by cytochrome P450 (CYP450)[1]. Rolofylline is alleviating the presynaptic dysfunction and restores neuronal activity as well as dendritic spine levels in vitro, is an interesting candidate to combat the hypometabolism and neuronal dysfunction associated with Tau-induced neurodegenerative diseases[2].

6-((tert-Butyldiphenylsilyl)oxy)hexan-1-ol

C22H32O2Si (356.21714519999995)

1H-Purine-2,6-dione, 8-(hexahydro-2,5-methanopentalen-3a(1H)-yl)-3,7-dihydro-1,3-dipropyl-

C20H28N4O2 (356.2212148)

C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent > C319 - Bronchodilator D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D045283 - Natriuretic Agents > D004232 - Diuretics

[(1S,2R,3R,4S,5S,6S)-4-azaniumyl-3-[(2R,3R,4R,5S,6R)-3-azaniumyl-6-(azaniumylmethyl)-4,5-dihydroxyoxan-2-yl]oxy-2,5,6-trihydroxycyclohexyl]-methylazanium

C13H32N4O7+4 (356.2270882)

(2e,4s)-4-[(2s,3s,4r,5s,6s,8r,9s,10r)-9-ethyl-4,10-dihydroxy-3,5,8-trimethyl-1,7-dioxaspiro[5.5]undecan-2-yl]pent-2-enoic acid

C19H32O6 (356.2198772)

(4r,5s,8s)-4-hydroxy-8-[(2s)-1-[(2s,3r)-3-[(2s)-2-hydroxy-3-methylbutyl]-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-5-methyloxocan-2-one

C19H32O6 (356.2198772)

(3s,4as,5r,6r)-7-[(1e)-hept-1-en-1-yl]-8-(hydroxymethyl)-2,2-dimethyl-4,5,6,8a-tetrahydro-3h-1-benzopyran-3,4a,5,6-tetrol

C19H32O6 (356.2198772)